PRECIGEN Investors


64th American Society of Hematology (ASH) Annual Meeting and Exposition

Dec 11, 2022 at 6:00 PM - 8:00 PM CST

An abstract (Abstract# 3334) titled, "A Phase1/1b Dose Escalation/Dose Expansion Study of PRGN-3007 UltraCAR-T Cells in Patients with Advanced Hematologic and Solid Tumor Malignancies," will be presented as a trial-in-progress presentation.